Showing results (721-730 of 1,171) with videos related to
Sort By:
Pageof 118
British Journal of Haematology|August 14, 2008
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphomaLuciano J Costa, Ivana N Micallef, David J Inwards, et al.Journal of Sports Sciences|October 30, 2004
Effects of physical activities that induce moderate external loading on bone metabolism in male athletesL Maïmoun, D Mariano-Goulart, I Couret, et al.The Science of the Total Environment|September 28, 2000
Evaluation of environmental levels and biological impact of TBT in Malta (central Mediterranean)V Axiak, A J Vella, D Agius, et al.British Journal of Haematology|September 21, 2001
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysisJ M Foran, A J Norton, I N Micallef, et al.British Journal of Haematology|May 22, 2008
Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantationLuciano J Costa, Andrew L Feldman, Ivana N Micallef, et al.Journal of Hematology & Oncology|July 4, 2015
Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantationLuis F Porrata, David J Inwards, Stephen M Ansell, et al.Cancer|February 19, 2010
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulationClive S Zent, Betsy R LaPlant, Patrick B Johnston, et al.The Journal of Hospital Infection|May 11, 2018
Real-world use of fidaxomicin in a large UK tertiary hospital: how effective is it for treating recurrent disease?D A Enoch, R Santos, C J Phillips, et al.Clinical & Developmental Immunology|April 24, 2010
Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomasLuis F Porrata, David J Inwards, Ivana N Micallef, et al.Drug Safety|October 29, 2021
A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019)Joelle Perri-Plandé, Ghada Miremont-Salamé, Joëlle Micallef, et al.Pageof 118